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Abstract
Background: Due to the spread of pyrethroid-resistance in malaria vectors in Africa, new strategies and tools are
urgently needed to better control malaria transmission. The aim of this study was to evaluate the performances of
a new mosaic long-lasting insecticidal net (LLIN), i.e. PermaNet® 3.0, against wild pyrethroid-resistant Anopheles
gambiae s.l. in West and Central Africa.
Methods: A multi centre experimental hut trial was conducted in Malanville (Benin), Vallée du Kou (Burkina Faso)
and Pitoa (Cameroon) to investigate the exophily, blood feeding inhibition and mortality induced by PermaNet®
3.0 (i.e. a mosaic net containing piperonyl butoxide and deltamethrin on the roof) comparatively to the WHO
recommended PermaNet® 2.0 (unwashed and washed 20-times) and a conventionally deltamethrin-treated net
(CTN).
Results: The personal protection and insecticidal activity of PermaNet 3.0 and PermaNet® 2.0 were excellent
(>80%) in the “pyrethroid-tolerant” area of Malanville. In the pyrethroid-resistance areas of Pitoa (metabolic
resistance) and Vallée du Kou (presence of the L1014F kdr mutation), PermaNet® 3.0 showed equal or better
performances than PermaNet® 2.0. It should be noted however that the deltamethrin content on PermaNet® 3.0
was up to twice higher than that of PermaNet® 2.0. Significant reduction of efficacy of both LLIN was noted after
20 washes although PermaNet® 3.0 still fulfilled the WHO requirement for LLIN.
Conclusion: The use of combination nets for malaria control offers promising prospects. However, further
investigations are needed to demonstrate the benefits of using PermaNet® 3.0 for the control of pyrethroid
resistant mosquito populations in Africa.
Background
Malaria remains a major public health problem. Last
global estimates of the malaria disease burden in 2006
indicate that at least 250 million clinical cases occurred
each year, with around 1 million deaths of which 90%
occurred in sub-Saharan Africa [1,2]. Recommendations
of the World Health Organization (WHO-Roll Back
Malaria programme) to combat malaria include
artemisinin-based combination therapy (ACT) and long-
lasting insecticidal nets (LLIN), supported by indoor
residual spraying of insecticide (IRS) and intermittent
preventive treatment in pregnancy (IPT) [2]. Recent
deployment of such strategies has showed important
reduction in malaria-associated morbidity and mortality
in settings with moderate to high transmission levels in
sub-Saharan Africa [3-5]. Eight LLINs are now recom-
mended by WHOPES for malaria control [6]. All of
them contain pyrethroids because of their fast and high
insecticidal properties on mosquitoes as well as their
low mammalian toxicity [7].
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spread in malaria vectors including Western [8], Central
[9], Eastern [10], and Southern Africa [11,12]. Resistance
mechanisms are divided into two groups: metabolic (i.e.
alterations in the levels or activities of detoxification
proteins) and target site (i.e. non-silent point mutations
within structural receptor genes) [13]. Mutations
(L1014F or L1014S) on the gene encoding for the
sodium channel, known as knockdown resistance (kdr),
cause resistance to DDT and/or pyrethroid insecticides
[14,15]. Over-expression of enzymes related to insecti-
cide resistance involves the cytochrome P450-dependent
monooxygenases (P450), the carboxylesterases (COE),
and the glutathione-S transferases (GST) [16]. Among
these three families, P450s can play a primary role in
pyrethroid detoxification and resistance in malaria vec-
tors as recently shown in Benin [17], Cameroon [18],
Ghana [19] and South Africa [20].
There are more and more evidences in the recent
literature to support that pyrethroid resistance may
seriously impact on malaria vector control [21]. An
experimental hut study carried out in southern Benin
in 2004 (Ladji) showed a rather low insecticidal effect
of permethrin-treated nets, at WHO recommended
dosages against Anopheles gambiae [22]. A recent study
carried out in the same locality with lambda-cyalothrin
used for ITNs and IRS showed a major loss of efficacy
associated with kdr resistance [23]. Reduced efficacy of
permethrin-impregnated bed nets against An. gambiae
strain sharing oxidase-based pyrethroid tolerance was
also reported in Cameroon [24] and Kenya [25,26].
Moreover, an increasing number of countries (such as
Benin, Ghana and Nigeria) reported the co-occurrence
of the L1014F kdr mutation and increased levels of
P450s within the same Anopheline populations [17,19].
As demonstrated in Culex quinquefasciatus, multiplica-
tive interaction (epistasis) between these two types of
resistance can lead to extremely high level of resistance
to pyrethroids [27,28]. Thus, the challenge is not only to
manage and control pyrethroid-resistant mosquitoes,
but also to deal with the development of “multiple resis-
tance” that may confer resistance to all insecticide
classes used in public health (i.e. DDT, carbamates,
etc.). Innovative tools are then urgently needed to
ensure more effective control of resistant malaria vectors
and to help developing countries to achieve the malaria-
related Millennium Development Goals i.e. 75% reduc-
tion of malaria burden until 2015 [2].
Among the new tools available in public health, Per-
maNet® 3.0, has been designed to improving efficacy
against pyrethroid-resistant mosquito populations [29].
PermaNet® 3.0 is a mosaic net combining deltamethrin-
coated-polyester side panels and a deltamethrin plus
piperonyl butoxide (PBO) incorporated-polyethylene
roof. PBO has been incorporated to the net as it showed
to enhance the effects of deltamethrin against insects by
inhibiting metabolic defence systems, mainly P450s [30].
In this paper, a multi centre study was carried out in
western and central Africa to evaluate the performances
of this new LLIN technology (PermaNet® 3.0) in com-
parison with the classical PermaNet® 2.0 recommended
by WHO. Experimental hut trials were conducted in
Malanville (Benin), Pitoa (Cameroon) and Vallée du Kou
(Burkina Faso), where An. gambiae populations showed
different levels and types of pyrethroid resistance (i.e.
metabolic versus target site modification). Standard
WHO procedures in phase II were followed to investi-
gate the efficacy of unwashed and 20 times washed
LLINs in terms of induced exophily, blood-feeding inhi-
bition and mortality.
Methods
Study areas
This study was conducted in three experimental stations
belonging to the Anopheles Biology & Control (ABC)
network (Figure 1). Two stations are located in western
Africa whereas the third one is located in Central Africa.
Each site presents different pattern of pyrethroid-resis-
tance among An. gambiae s.l. populations.
Malanville (11°87N; 03°38E) is in northern Benin,
800 km from Cotonou, in an irrigated rice-growing
valley. The climate is tropical soudanian, characterized
by a dry season from December to June and a rainy sea-
son from July to November. Anopheles gambiae s.s.
M cytotype is the main malaria vector in this area and
presents very low levels of pyrethroid resistance [31].
Pitoa (9°21N; 13°31E) is a small village, with around
5,000 inhabitants, located at 15 km from Garoua, in
an area of extensive cotton cultivation in Northern Camer-
oon (around 35 000 ha cultivated). Anopheles gambiae s.l.
and Anopheles funestus s.l. are the main malaria vectors
in this area. Anopheles arabiensis is predominant
and showed moderate level of resistance to permethrin,
deltamethrin and DDT [32] due to increased oxidase and
esterase activity [18,33].
Vallée du Kou is a large rice-growing area (1,200 ha),
located at 30 km Northern Bobo-Dioulasso and com-
prised seven villages, surrounded by wooded savannah.
VK7 (11°24N; 4°24E) is a village located on the out-
skirts of rice fields. Both M & S molecular forms of
An. gambiae co-exist in sympatry but the M form is
mostly present during the dry season [34]. Anopheles
gambiae showed high level of resistance to pyrethroids
due to the presence of the Kdr mutation occurring at
high allelic frequency among the molecular M and S
forms [35].
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An. gambiae s.l
In each site (Malanville, Pitoa and Vallée du Kou) and
just prior to the trials, resistance of An. gambiae s.l.t o
pyrethroids was checked using WHO cylinder test [36].
Four batches of 25 unfed females, aged 2-5 days, were
exposed to deltamethrin-impregnated papers for 1 h
(0.05%) and held to observe mortality after 24 h, then
stored at 4°C for further molecular studies. A sub-sample
of 30 mosquitoes per locality was identified to sibling
species and for the relative frequency of the molecular
M & S forms using standard PCR methods [37,38]. The
method of Martinez-Torrez et al [14] was used for the
molecular detection of the L1014F kdr mutation.
Study design and experimental huts
Experimental huts are specially designed to test vector
control products against freely entering mosquitoes
under natural but controlled conditions [36]. The 3.5 ×
2 × 2 m huts were built with local materials and
designed with four entry baffles that enabled mosquitoes
to fly into the hut but then hindered their escape from
the hut. A veranda trap made of polyethylene sheeting
and mesh screening (2 m long × 1.5 m wide × 1.5 m
high) projected from the back wall of each hut. Move-
ment of mosquitoes between the huts and the verandas
was unimpeded during the night. Each hut rested on a
concrete base surrounded by a water-filled moat to pre-
vent entry of ants that would otherwise eat mosquitoes
knocked down on the floor of the hut.
In each country, the treatments were randomly allo-
cated to six experimental huts, which did not differ
between them for their mosquito attractiveness in
absence of treatment. Adult volunteers have been
recruited among the inhabitants of the villages where
experimental huts were implemented. They have been
informed on the objective of this study and signed (or
through a literate witness if illiterate) an informed
consent. They entered the hut at dusk (7:00pm) and
remained inside until dawn (5:30 am) of the next morn-
ing. Early in the morning, dead mosquitoes were col-
lected from the floor of the hut as well as from the exit
traps and inside the nets; resting mosquitoes were col-
lected using aspirators from inside the net and from the
walls and roof of the hut and exit traps. Mosquitoes
were scored by location as dead or alive and as fed or
Figure 1 Experimental hut stations belonging to the Anopheles Biology & Control (ABC) network. Huts from Malanville (Northern Benin),
Pitoa (Northern Cameroon), and Bobo-Dioulasso (Southern Burkina Faso) were used in this study.
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provided with access to sugar solution for 24 hours to
assess the delayed mortality. To minimize bias related to
mosquito attractiveness of each volunteer and spatial
variation in mosquito densities, the volunteers and bed
nets were rotated between huts each day according to a
Latin square design [36].
Efficacy of each treated arms was expressed in terms
of deterency, induced exophily, blood-feeding inhibition,
and mortality. This multi-centre trial included the deter-
mination of the efficacy of unwashed and 20 times
washed PermaNet® 3.0 comparatively to the WHO
recommended PermaNet® 2.0 and a conventional delta-
methrin-treated net washed to just before exhaustion (as
defined by WHOPES guidelines [33]). Their impact on
the behaviour of wild pyrethroid resistant An. gambiae
s.l. and An. arabiensis mosquitoes was also evaluated.
Mosquito net treatments
In each country, six treated arms were randomly allo-
cated to huts:
1. Untreated net (same fabric - polyester on the side
with a strengthened 70 cm lower border/polyethylene
on top)
2. PermaNet® 3.0 unwashed
3. PermaNet® 2.0. unwashed
4. PermaNet® 3.0 washed 20 times
5. PermaNet® 2.0 washed 20 times
6. Polyester net conventionally treated with deltame-
thrin at 25 mg a.i./m
2 and washed to just before exhaus-
tion i.e. 95% Knock down after 1 h of contact and/or
80% mortality after 24 h [36].
The LLINs (PermaNet® 2.0 and PermaNet® 3.0) were
provided by Vestergaard Frandsen SA, (Switzerland).
PermaNet® 2.0 is a deltamethrin-coated LN, made of
knitted multi-filament polyester fibres and is treated
with deltamethrin at a target concentration of 55 mg/m
2
(= 1.8 g/kg for a 75-denier net used in Malanville and
Pitoa and = 1.4 g/kg for a 100-denier net in Vallée du
kou). PermaNet® 2.0 received WHOPES full recommen-
dation for LLIN in 2009. PermaNet® 3.0 product is a
combination of different long-lasting technologies. The
roof of PermaNet® 3.0 utilizes deltamethrin and PBO
incorporated into monofilament polyethylene yarn of
100 denier (warp-knitted fabric, with weight of 40 ±
15% g/m
2)a tt h et a r g e td o s a g eo f4 . 0gA I / k ga n d2 5g
AI/kg of netting material, respectively. The side panels
of PermaNet® 3.0 are made of multi-filament polyester
fibres, treated with deltamethrin in a resin coating
(75 denier, warp-knitted fabric, atlas construction). The
side netting has two parts: a strengthened lower part,
so-called border (70 cm) by using 75 denier yarn
(weight 40 ± 10% g/m
2)a n das i d ep a n e lm a d eo f7 5
denier (weight of 30 ± 10% g/m
2) .T h et a r g e td o s eo f
deltamethrin in the side panels is 2.8 g AI/kg of netting
material, i.e. 115 mg AI/m
2 of the border and 85 mg
AI/m
2 of the remaining of the side panels.
The polyester net was conventionally treated with del-
tamethrin at 25 mg AI/m
2 and washed to just before
the point of exhaustion (i.e. <80% mortality or <95%
knock down). This treatment was used as a positive
control. Each net was deliberately holed with six holes
(4 cm × 4 cm) to simulate a torn net [36].
Residual activity and wash resistance of the net
treatments
The bio-efficacy of each treatment was determined before
washing and after field testing by exposing 2 to 5 days old
unfed females of the susceptible An. gambiae Kisumu strain
in WHO cone bioassays [36]. This test consists to expose
female mosquitoes to each part of the nets for 3 min and to
measure the knock down time after 60 minutes and the
mortality after 24 H. A mean of 50 mosquitoes was tested
per net and results pooled for analysis. Sugar solution was
provided during the 24-h holding period, and the tempera-
t u r ew a sk e p ta ta r o u n d2 5 ° C .T h es t a n d a r d i z e dW H O
protocol was used for washing the nets [36].
Chemical analysis
Determination of deltamethrin and PBO content on
nets, before washing and after the field testing was
investigated using a new method developed by the
WHO Collaborating Centre for the Quality Control of
Pesticides (Walloon Agricultural Research Centre, Gem-
bloux, Belgium)[39]. In each country, five pieces of net-
ting (about 30 cm × 30 cm) were cut from the roof and
side panel and stored in aluminium foil for subsequent
chemical analysis. The side panels and roof were tested
separately for the PermaNet® 3.0. The chromatographic
determination of deltamethrin, deltamethrin R-isomer
and piperonyl butoxide was performed by gas chromato-
graphy with flame ionization detection (GC-FID) after
extraction by refluxing with xylene. Before the analysis
of samples, the analytical method was successfully vali-
dated for its specificity, linearity of detector response,
accuracy, repeatability and reproducibility.
Statistical analysis
Data from in situ bioassays were compared between
each net using a Chi square test at 95% confidence
interval, using the Minitab software version 12.2. In
each study site, the number of mosquitoes of each spe-
cies entering the huts was compared by species and ana-
lysed using the non parametric Kruskal-Wallis test. The
proportion of mosquitoes that exited early (induced
exophily), the proportion that was killed within the hut
(mortality) and the proportion that successfully blood
fed (blood feeding rate) were compared and analysed
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2006). The percentage personal protection (PP) was
calculated as (BFC-BFT)/(BFC) * 100, where BFC is the
total number of blood fed females in the control hut
and BFT the total number of blood-fed female mosqui-
toes in the treated hut. The overall killing effect (KE) of
a treatment was calculated as (DT-DC)/(TC) * 100,
where DT is the total number of dead mosquitoes in
the treated hut, DC the total number of dead mosqui-
toes in the control hut and TC is the total number of
mosquitoes collected in the control hut [36].
Results
Vector population and pyrethroid resistance
Table 1 summarizes the sibling species, molecular forms
and pyrethroid resistance status of An. gambiae s.l.c o l -
lected in the three experimental hut stations. Anopheles
gambiae s.s. was predominant in Malanville (95%) and
Vallée du Kou (100%), whereas An. arabiensis was pre-
dominant (95%) in Pitoa. The composition of An. gam-
biae s.s. was 100% M form for the Malanville sample
and 80%/20% S/M molecular forms for the Kou Valley
sample. Different levels of deltamethrin resistance were
reported in the three study sites; the most “susceptible”
population was found in malanville (i.e. 85% mortality
to deltamethrin), the most resistant in Vallée du Kou
(23% mortality) and the population of Pitoa being inter-
mediate (70% mortality). The kdr mutation was present
at very high frequency (>80%) in both molecular M & S
forms in Vallée du Kou whereas it was only 16% in the
M form in Malanville. In Pitoa, the kdr mutation was
almost absent (<5%) and deltamethrin resistance in
An. arabiensis was associated with elevated esterase and
oxidase activities as described previously [18,33].
Insecticide residual activity
With conventionally deltamethrin-treated nets (CTN),
KD and mortality decreased below the WHO threshold
(95% and 80% respectively) after four washes (respec-
tively 73% and 71%). Hence, three washes were consid-
ered as the number of washes required before
exhaustion. Residual activity of PermaNet® 2.0 and Per-
maNet® 3.0 as measured by WHO cone bioassay tests
showed no significant decrease in efficacy after washing
and/or field testing (Table 2).
Efficacy of treatments in experimental huts
The experimental hut trials were conducted from Sep-
tember till November 2007 in the Vallée du Kou and
from July till September 2008 in Malanville and Pitoa.
Thirty-six night collections (one Latin square) were
required in Vallée du Kou and Pitoa to collect sufficient
number of Anopheline mosquitoes for statistical analy-
sis, whereas 72 nights collection (two Latin squares)
were required in Malanville to obtain a correct density.
In overall, 1,594 An. gambiae s.l. mosquitoes were col-
lected in the control (untreated) huts among which 908
(equivalent 19 Anopheles bites per man per night), 401
(eq. 5.8 bites per man per nigh) and 285 (eq.1.5 bites
per man per man) were found in Vallée du Kou, Pitoa
and Malanville, respectively.
Deterency
A significant reduction in entry rates (deterrency) was
noted with the unwashed PermaNet® 2.0 and 3.0 in Val-
lée du Kou and Pitoa compared to the untreated (con-
trol) arm whereas no significant reduction was noted in
Malanville regardless the treatments (P < 0.05, see Addi-
tional file 1).
Induced exophily
In the control huts, the exophily in Pitoa did not differ
significantly from the two others study sites, but the
exophily rate in Malanville was significantly higher than
in Vallée du Kou (p = 0.018) (see Additional file 1). The
exophily induced by each treated hut is illustrated in
Figure 2 and summarized in Additional file 2. The pro-
portion of mosquitoes found in the veranda trap with
Table 1 Species, molecular forms and pyrethroid resistance status of An. gambiae s.l in the three experimental hut
stations.
Country Species Molecular
form *
Kdr
frequency
Mortality
%* *
Resistance
status ***
An. gambiae
s.s.
An. arabiensis
Malanville
(Benin)
95% 5% 100% M 16% 85% Resistance
suspected
(kdr mutation,
oxidase)
Pitoa
(Cameroon)
5% 95% 100% S <5% 70% Resistance
(oxidase
+Esterase)
Vallée du kou
(Burkina Faso)
100% 0% 15%
M
85%
S
>80
%M
>80
%S
23% Resistance
(kdr mutation)
*An. gambiae s.s. **deltaméthrine 0.05%, *** from [30 and][17]
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greater in Vallée du Kou (from 67 to 80%) than in Pitoa
and Malanville (from 51 to 67%). Both LLINs (washed
or unwashed) induced significantly more exophily than
the untreated nets, regardless of the ecological settings.
PermaNet® 3.0 (washed or unwashed) did not induce
significantly higher exophily than PermaNet® 2.0
(washed or unwashed), except in Vallée du Kou where
the proportion of mosquitoes found in the veranda trap
was higher with PermaNet® 3.0 washed 20 times (75%)
than PermaNet® 2.0 washed 20 times (67%) (P < 0.05).
BFI and personal protection
The proportion of mosquitoes that succeeded to take a
blood meal with untreated holed nets was significantly
Table 2 Residual activity (as determined by WHO cone bioassays on susceptible Kisumu strain) of unwashed and
washed Permanet 2.0 and Permanet 3.0 in comparison with Conventionally Treated nets (CTN) washed to just before
exhaustion in the three experimental hut stations.
Country Conditions Untreated
net
Permanet 2.0
unwashed
Permanet 2.0 20×
washed
Permanet 3.0
unwashed
Permanet 3.0 20×
washed
CTN*
Before
washing
0.0
a (52) 100
b (52) 100
b (53) 100
b (54) 100
b (53) 100
b
(53)
Malanville
(Benin)
After washing
or
field testing
0.0
a (56) 100
b (63) 97
b (62) 100
b (61) 100
b (59) 89
c
(64)
Before
washing
0.0
a (52) 100
b (55) 100
b (55) 100
b (50) 100
b (56) 100
b
(54)
Pitoa
(Cameroon)
After washing
or
field testing
3.6
a (56) 100
b (63) 98
b (61) 100
b (65) 100
b (60) 81
c
(63)
Before
washing
0.0
a (56) 100
b (55) 100
b (57) 100
b (59) 100
b (59) 100
b
(58)
Vallée du
Kou
(Burkina
Faso)
After washing
or
field testing
0.0
a (62) 100
b (63) 98
b (59) 100
b (55) 100
b (54) 95
b
(57)
* Three washes were required to reach the point to just before exhaustion.
Two Values in the same raw sharing same letter do not significantly differ (P > 0.05).
Values in bold represent the number of tested mosquitoes per treatment.
Figure 2 Comparison of Induced Exophily obtained for unwashed and washed PermaNet® 2.0, PermaNet® 3.0 and CTN against free
flying An.gambiae s.l. in experimental huts.
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of blood fed females caught; p = 0.0205) and Vallée du
Kou (75% of blood fed females caught; p = 0.0002) (see
Additional file 2).
The blood feeding inhibition (BFI) rates induced by
each treated hut are illustrated in the Figure 3 and sum-
marized in Additional file 2. The proportion of mosqui-
toes that succeeded to take a blood meal in the treated
huts differed according to the study site; the BFI ranged
from 65 to 98% in Malanville, from 45 to 71% in Pitoa
and from 34 to 72% in Vallée du Kou. In Malanville, the
BFI of PermaNet® 3.0 washed 20 times (65%) was signifi-
cantly lower than for Permanet® 3.0 unwashed (98%) and
PermaNet® 2.0 unwashed or washed 20 times (respec-
tively 90% and 84%). In Pitoa, PermaNet® 2.0 induced a
higher BFI, although this was only significant for
unwashed nets. In contrast, BFI was higher with Perma-
Net® 3.0 over PermaNet® 2.0 in Vallée du Kou for both
unwashed and washed bed nets (P < 0.05).
The personal protection of PermaNet® 2.0 and 3.0 was
good when the LLIN was unwashed (from 80% in Pitoa
to 99% in Malanville) but much lower when the nets
were washed 20 times, especially in the pyrethroid resis-
tance area of Vallée du Kou (44% and 62% for Perma-
Net® 2.0 and PermaNet® 3.0 respectively). In this
resistance area of Vallée du Kou, PermaNet® 3.0 con-
ferred a significantly better protection than the Perma-
Net® 2.0 (p = 0.0006 for unwashed LLINs; p = 0.0024
for washed LLINs).
Insecticidal activity
Mortality of mosquitoes in the control huts was low
(around 5%) in Malanville and Vallée du Kou where
An. gambiae s.s. was predominant. In contrast,
higher mortality (13%) was recorded in Pitoa where
An. arabiensis was found in higher proportion.
The mortality induced by each treated arm is illu-
strated in Figure 4 and summarized in Additional file 3.
As for the blood feeding behaviour, the proportion of
An. gambiae killed by the treated nets greatly differed
according to the entomological setting. The corrected
mortality was high in Malanville (from 61% for CTN to
96% for PermaNet® 3.0) and, in a lesser extent, Pitoa
(from 41% for CTN to 93% for PermaNet® 3.0). In con-
trast, the mortality in Vallée du Kou ranged from 28%
for CTN to 78% for PermaNet® 3.0. Regarding the
LLINs only, mortality (~69%) was similar between Per-
maNet® 3.0 and PermaNet® 2.0 washed 20 times in
Malanville whereas in Pitoa and Vallée du Kou Perma-
Net® 3.0 (washed or unwashed)i n d u c e ds i g n i f i c a n t l y
more mortality than PermaNet® 2.0 (p < 0.05). In all set-
tings, washing the nets 20 times significantly reduced
the number of mosquitoes being killed by the LLINs
(p < 0.05).
The overall insecticidal effects of unwashed PermaNet®
2.0 and PermaNet® 3.0 were high in Malanville and
Pitoa (from 80 to 96%) comparatively to Vallée du Kou
(from 41 to 77%). This trend was stronger with washed
LLINs especially in Vallée du Kou where the insecticidal
Figure 3 Comparison of Blood Feeding Inhibition (BFI) rates obtained for unwashed and washed PermaNet® 2.0, PermaNet® 3.0 and
CTN against free flying An.gambiae s.l. in experimental huts.
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to 46% and 26%, respectively (see Additional file 3). The
side effect questionnaires collected during the field trials
did not reveal any adverse effects (symptoms or trou-
bles) related to the use of any treated arms.
Deltamethrin and PBO content on mosquito nets
In the three study sites, neither deltamethrin nor PBO
was detected (limit of quantification = 0.01 g/kg for del-
tamethrin and 0.1 g/kg for PBO) in the untreated nets,
hence confirming that no contamination occurred
d u r i n gt h er o t a t i o n so ft h en e t s( T a b l e3 ) .T h ea c t i v e
ingredient content for unwashed PermaNet® 3.0 (delta-
methrin and PBO) and PermaNet® 2.0 (deltamethrin)
complied with the target doses (± 25%), except for one
PermaNet® 2.0 (Pitoa) for which the average deltame-
thrin content on the side panels (2.53 g AI/kg) was just
above the upper limit (2.25 g AI/kg) of the target dose.
No major loss of deltamethrin and/or PBO content
(from nil to 17%) was reported for unwashed PermaNet®
2.0 (deltamethrin) and PermaNet® 3.0 (deltamethrin and
PBO) after the field testing. However, the loss of delta-
methrin after 20 washes was relatively important for
both PermaNet® 2.0 (from 59 to 85%) and PermaNet®
3.0 in the side panels (from 71 to 87%). However, the
deltamethrin and PBO content in the roof panel
remained high (>60% retention) in PermaNet® 3.0 after
20 washes. The deltamethrin content for unwashed
CTN (0.8 g AI/kg) complied with the initial target doses
(± 25%). After 3 washes the loss of active ingredient
ranged from 85 to 91%.
Discussion
A multi-centre experimental hut study was carried out to
assess the efficacy of PermaNet® 3.0 against wild pyre-
throid-tolerant An. gambiae s.s. (Malanville), kdr-resistant
An. gambiae s.s. (Vallée du Kou) and pyrethroid-resistant
An. arabiensis s.l. showing metabolic resistance (Pitoa).
The ABC network offers ideal conditions to address this
objective based on the existence of eight experimental hut
stations in different ecological and entomological settings
(Figure 1). In the present study, three stations where
An. gambiae s.l. showed different level and type of resis-
tance to pyrethroids were selected to assess whether Per-
maNet® 3.0 may represent a more potent technology than
PermaNet® 2.0 against pyrethroid resistant mosquito
populations.
Differences in behavioural responses between wild
Anopheline populations
The results from the control huts showed that the beha-
vioural preferences of Anopheline populations (in terms
of endophily/exphily) significantly differ between the
three sites as expected from literature on trophic beha-
viour of malaria vectors [40-42]. It confirms that the
behaviour of Anopheline populations depend on several
Figure 4 Comparison of corrected mortality rates obtained for unwashed and washed PermaNet® 2.0, PermaNet® 3.0 and CTN against
free flying An.gambiae s.l. in experimental huts.
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resistance mechanisms and other environmental vari-
ables [40-42]. Interestingly, there is a difference in mor-
tality rate in the control huts between An. arabiensis
collected in Pitoa (12%) and the two others An. gambiae
populations from Malanville and Vallée du Kou (<5%).
Unfortunately, this study did not allow to decipher on
the causes of this difference of mortality (behavioural
preference, environmental conditions, etc.) but other
authors have already reported similar mortality rates of
An. arabiensis (10%) in experimental huts [43]. Never-
theless these differences shed light on the need for
further investigations on behavioural preferences of wild
populations of An. gambiae s.s. and An. arabiensis.
Comparison between PermaNet® 2.0 and 3.0
The chemical analysis confirmed that in overall,
unwashed nets were impregnated with the appropriate
target dose of deltamethrin and PBO. Although efficacy
of 20 times washed PermaNet® 3.0 and PermaNet® 2.0
was good, a rather high loss of insecticide was noted in
the side panels (Table 3). Nevertheless, the deltamethrin
and PBO retention in the roof was around 2.5 times
higher than that of deltamethrin in the side panels,
showing that the retention is better with incorporated
polyethylene than with coated polyester [39].
This study first demonstrated a better or equal impact of
PermaNet® 3.0 washed 20 times on mortality and blood
feeding inhibition of major malaria vectors compared with
Table 3 Determination of deltamethrin and PBO content on mosquito nets in the three experimental hut trials.
Country Treatment Target dose* Deltamethrin/PBO content (g/kg) Loss of active ingredient (%)
g/kg (IC95) Before washing
and testing
After testing g/kg (IC95)
Malanville
(Benin)
Untreated net 0 <0.01 <0.01
Permanet 2.0 1.8 [1.35-2.25] 2.09 1.74 17%
Permanet 2.0 20× 1.8 [1.35-2.25] 2.41 0.99 59%
Permanet 3.0 2.8 [2.1-3.5] 2.61 2.32 11%
Permanet 3.0 Roof 4 [3-5] 3.69 3.00 19%
Permanet 3.0 20× 2.8 [2.1-3.5] 2.58 0.53 79%
Permanet 3.0 roof 20× 4 [3-5] 3.69 3.16 14%
CTN exhausted 0.8 [0.6-1.0] 0.59 0.09 85%
PBO Permanet 3.0 25 [18.75-31.25] 20.8 23.1 +11%
PBO Permanet 3.0 20× 26 [18.75-31.25] 20.7 12.4 40%
Pitoa
(Cameroon)
Untreated net 0 <0.01 <0.01
Permanet 2.0 1.8 [1.35-2.25] 2.53 2.51 1%
Permanet 2.0 20× 1.8 [1.35-2.25] 2.65 0.41 85%
Permanet 3.0 2.8 [2.1-3.5] 2.44 2.50 -3%
Permanet 3.0 Roof 4 [3-5] 3.21 3.22 0%
Permanet 3.0 20× 2.8 [2.1-3.5] 2.48 0.33 87%
Permanet 3.0 roof 20× 4 [3-5] 3.38 2.57 24%
CTN exhausted 0.8 [0.6-1.0] 0.88 0.08 91%
PBO Permanet 3.0 25 [18.75-31.25] 26.0 29.8 +15%
PBO Permanet 3.0 20× 26 [18.75-31.25] 28.0 17.7 37%
Vallée du kou
(Burkina Faso)
Untreated net 0 <0.01 <0.01
Permanet 2.0 1.4 [1.05-1.75] 1.31 1.32 -1%
Permanet 2.0 20× 1.4 [1.05-1.75] 1.30 0.27 79%
Permanet 3.0 2.8 [2.1-3.5] 2.89 2.94 +2%
Permanet 3.0 Roof 4 [3-5] 4.33 4.07 6%
Permanet 3.0 20× 2.8 [2.1-3.5] 3.10 0.90 71%
Permanet 3.0 roof 20× 4 [3-5] 4.18 3.36 20%
CTN exhausted 0.8 [0.6-1.0] 0.72 0.11 85%
PBO Permanet 3.0 25 [18.75-31.25] 23.1 20.4 12%
PBO Permanet 3.0 20× 26 [18.75-31.25] 22.9 15.1 34%
* Target dose for Permanet 2.0 was 1.8 g/kg ± 25% for 75 denier’s nets in Benin and Cameroon and 1.4 g/kg ± 25% for 100 deniers net in Burkina Faso
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(25 mg/m
2 AI) washed until just before exhaustion. This
confirms that the PermaNet® 3.0 fulfils the WHOPES effi-
cacy criteria of Phase II studies for LLIN.
Regarding the two LLINs, unwashed Permanet 3.0
induced significantly higher BFI and mortality than Per-
manet 2.0 in Vallée du Kou and Malanville. In the local-
ity of Pitoa, the BFI was however higher with Permanet
2.0 than Permanet 3.0 but the mortality was still higher
with Permanet 3.0. After 20 washes, the PermaNet® 3.0
also induced higher insecticidal effect than PermaNet®
2.0 in the pyrethroid resistance areas of Pitoa and Vallée
du Kou, but performed equally in the area of Malanville.
One should note that in areas with high resistance
levels (Vallée du Kou) 50% of resistant mosquitoes sur-
vived after exposure to PermaNet® 3.0 relative to 75%
survival after exposure to PermaNet® 2.0. It remains to
be seen if the gain of efficacy of PermaNet® 3.0 over Per-
maNet® 2.0 is enough to control highly pyrethroid-resis-
tant malaria vector populations. Here, it is difficult to
conclude on the benefit of using PBO on the roof
because the deltamethrin content on PermaNet® 3.0 was
approximately twice higher than that of PermaNet® 2.0.
So the better efficacy on resistant mosquitoes could be
impeded either to the higher deltamethrin concentration
or to the PBO itself or both. Other field studies did not
show an increase of efficacy on resistant Culex and
pyrethroid susceptible An. gambiae s.s.[ 4 4 ]a sw e l la s
deltamethrin-resistant Anopheles epiroticus [45].
The threat of insecticide resistance mechanisms
This multi-centre study provided also more evidence
that pyrethroid resistance can seriously reduce the effi-
cacy of pyrethroid -treated materials in malaria vectors
[21,22]. Results obtained in Vallée du Kou showed a
strong reduction of ITNs efficacy where the kdr muta-
tion frequency was high (e.g. personal protection of
CTN washed to just before exhaustion ranged from 88%
in Malanville to 24% in Vallée du Kou and the insectici-
dal effect ranged from 60% in Malanville to 25% in Val-
l é ed uK o u ) .T h es a m et r e n dw a so b s e r v e dw i t h
PermaNet® 2.0, confirming that the Kdr mutation is an
important predictor of pyrethroid resistance phenotype
in malaria vectors as previously described [23,46]. Lower
insecticidal activity and personal protection were already
demonstrated in West Africa with pyrethroid resistant
mosquito populations using either Olyset® net or Perma-
Net® [47] and also insecticide treated plastic sheetings
[48]. Unfortunately, in most malaria endemic countries,
An. gambiae populations are sharing very high fre-
quency of Kdr mutation [8,49-51] alone or in combina-
tion with metabolic resistance [16,18]. In Pitoa, where
An. arabiensis show higher metabolism through elevated
oxidase and esterase activity [33], CTN efficacy was
intermediate (PP and IE were 63.6% and 33.2%, respec-
tively), suggesting that metabolic resistance could also
reduce ITN efficacy [24]. This finding supports the glo-
bal warning about the spread of the pyrethroid resis-
tance although there is no evidence yet for a malaria
control failure using LLIN at an operational scale [52].
Conclusion
To summarize, the present study showed that the new
long-lasting bed nets PermaNet® 3.0 caused better effi-
cacy against both Kdr and metabolic resistant malaria
vectors than PermaNet® 2.0. Nevertheless in areas of
strong resistance like the Vallée du Kou, a large number
of exposed mosquitoes survived after exposure to both
LLINs. Then as a short term prospect, it seems essential
to evaluate this tool in others areas of strong resistance
like southern Benin, southern Nigeria and Côte d’Ivoire.
It is also crucial to strengthen the collaboration between
companies and Research Institutions to find alternative
tools for malaria vector control (e.g. using mixtures of
unrelated compounds for LLINs [53-57] and/or the use
of insecticide-treated plastic sheeting and LLINs [58]),
because the race towards an insecticide with a new
mode of action will be long and expensive.
Additional file 1: Comparison of exophily obtained for free flying
wild Anopheles gambiae in experimental huts of all countries. Raw
data from the experimental hut trials.
Additional file 2: Comparison of blood feeding rates obtained for
free flying wild Anopheles gambiae in experimental huts of all
countries. Raw data from the experimental hut trials.
Additional file 3: Comparison of mortality rates obtained for free
flying wild Anopheles gambiae in experimental huts of all countries.
Raw data from the experimental hut trials.
Acknowledgements
The experimental hut trial performed in Malanville (Benin) was carried out
within the framework of the WHO Pesticide Evaluation Scheme (WHOPES)
initiative for research and development of alternative insecticides for vector
control. Trials carried out in Pitoa (Cameroon) and the Vallée du Kou
(Burkina Faso) were supported by a grant from Vestergaard Frandsen SA,
(Switzerland). We are grateful to the team of Malanville, Pitoa and the Vallée
du Kou for their excellence during field work, and the people of these
villages for their hospitality. We also thank Mr. Nicolas Moiroux for having
set up of the map of the ABC network and Dr. Pennetier Cedric for revising
the manuscript.
Author details
1Institut de Recherche pour le Développement (IRD), UR016, Caractérisation
et Contrôle des Populations de Vecteurs, 01 BP 4414 RP Cotonou,
République du Bénin.
2Centre de Recherche Entomologique de Cotonou
(CREC), 06 BP 2604 Cotonou, République du Bénin.
3Institut de Recherche en
Sciences de la Santé (IRSS)/Centre Muraz (CM), 01 BP 390, Bobo-Dioulasso,
Burkina Faso.
4Organisation de Coordination pour la lutte contre les
Endémies en Afrique Centrale (OCEAC), BP. 288, Yaoundé, Cameroon.
5Walloon Agricultural Research Centre (CRA-W), Agriculture and Natural
Environment Department, Plant Protection Products and Biocides Physico-
chemistry and Residues Unit, Rue du Bordia, 11 B-5030, Gembloux, Belgium.
6Institut de Recherche pour le Développement (IRD), BP 1386 Dakar,
République du Sénégal.
Corbel et al. Malaria Journal 2010, 9:113
http://www.malariajournal.com/content/9/1/113
Page 10 of 12Authors’ contributions
VC designs the study and drafted the manuscript. JC, RDD, JE, PN carried
out bioassays and conducted the experimental hut trials. OP conducted the
chemical analysis on nets. MA and JMH helped design the study and
critically revised the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors received financial support from Vestergard Frandsen Company
to carry out the experimental huts trials in Burkina Faso and Cameroon.
However, the authors have strictly followed the WHOPES procedures for
testing and evaluation of the efficacy of Permanet 3.0 against malaria
vectors. The Research teams involve in this study (i.e. IRD, CREC, OCEAC, CM
and CRA-W) have no competing and commercial interests with the
manufacturer.
Received: 18 February 2010 Accepted: 27 April 2010
Published: 27 April 2010
References
1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The global distribution
of clinical episodes of Plasmodium falciparum malaria. Nature 2005,
434:214-217.
2. WHO: World Malaria Report Geneva: World Health
OrganizationWorld_Health_Organization 2008, 215.
3. Lengeler C: Insecticide-treated bed nets and curtains for preventing
malaria. Cochrane Database of Systematic reviews 2009, , 2: 1-58.
4. Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC: Modelling the
impact of artemisinin combination therapy and long-acting treatments
on malaria transmission intensity. PLoS Med 2008, 5:e226, discussion e226.
5. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ: Reduction of
transmission from malaria patients by artemisinin combination
therapies: a pooled analysis of six randomized trials. Malar J 2008, 7:125.
6. Zaim M, Aitio A, Nakashima N: Safety of pyrethroid-treated mosquito
nets. Med Vet Entomol 2000, 14:1-5.
7. WHO: WHO recommended long-lasting insecticidal mosquito nets.[http://
www.who.int/whopes/Long_lasting_insecticidal_nets_Aug09.pdf].
8. Chandre F, Manguin S, Brengues C, Dossou Yovo J, Darriet F, Diabate A,
Carnevale P, Guillet P: Current distribution of a pyrethroid resistance
gene (kdr) in Anopheles gambiae complex from west Africa and further
evidence for reproductive isolation of the Mopti form. Parassitologia
1999, 41:319-322.
9. Etang J, Fondjo E, Chandre F, Morlais I, Brengues C, Nwane P,
Chouaibou M, Ndjemai H, Simard F: First report of knockdown mutations
in the malaria vector Anopheles gambiae from Cameroon. Am J Trop Med
Hyg 2006, 74:795-797.
10. Stump AD, Atieli FK, Vulule JM, Besansky NJ: Dynamics of the pyrethroid
knockdown resistance allele in western Kenyan populations of
Anopheles gambiae in response to insecticide-treated bed net trials. Am
J Trop Med Hyg 2004, 70:591-596.
11. Hargreaves K, Koekemoer LL, Brooke BD, Hunt RH, Mthembu J, Coetzee M:
Anopheles funestus resistant to pyrethroid insecticides in South Africa.
Med Vet Entomol 2000, 14:181-189.
12. Hargreaves K, Hunt RH, Brooke BD, Mthembu J, Weeto MM, Awolola TS,
Coetzee M: Anopheles arabiensis and An. quadriannulatus resistance to
DDT in South Africa. Med Vet Entomol 2003, 17:417-422.
13. Lapied B, Pennetier C, Apaire-Marchais V, Licznar P, Corbel V: Innovative
applications for insect viruses: towards insecticide sensitization. Trends
Biotechnol 2009, 27:190-198.
14. Martinez Torres D, Chandre F, Williamson MS, Darriet F, Berge JB,
Devonshire AL, Guillet P, Pasteur N, Pauron D: Molecular characterization
of pyrethroid knockdown resistance (kdr) in the major malaria vector
Anopheles gambiae s.s. Insect Mol Biol 1998, 7:179-184.
15. Ranson H, Jensen B, Vulule JM, Wang X, Hemingway J, Collins FH:
Identification of a point mutation in the voltage-gated sodium channel
gene of Kenyan Anopheles gambiae associated with resistance to DDT
and pyrethroids. Insect Mol Biol 2000, 9:491-497.
16. Hemingway J, Hawkes NJ, McCarroll L, Ranson H: The molecular basis of
insecticide resistance in mosquitoes. Insect Biochem Mol Biol 2004,
34:653-665.
17. Djouaka RF, Bakare AA, Coulibaly ON, Akogbeto MC, Ranson H,
Hemingway J, Strode C: Expression of the cytochrome P450s, CYP6P3
and CYP6 M2 are significantly elevated in multiple pyrethroid resistant
populations of Anopheles gambiae s.s. from Southern Benin and Nigeria.
BMC Genomics 2008, 9:538.
18. Muller P, Chouaibou M, Pignatelli P, Etang J, Walker ED, Donnelly MJ,
Simard F, Ranson H: Pyrethroid tolerance is associated with elevated
expression of antioxidants and agricultural practice in Anopheles
arabiensis sampled from an area of cotton fields in Northern Cameroon.
Mol Ecol 2008, 17:1145-1155.
19. Muller P, Warr E, Stevenson BJ, Pignatelli PM, Morgan JC, Steven A,
Yawson AE, Mitchell SN, Ranson H, Hemingway J: Field-caught permethrin-
resistant Anopheles gambiae overexpress CYP6P3, a P450 that
metabolises pyrethroids. PLoS Genet 2008, 4:e1000286.
20. Wondji CS, Irving H, Morgan J, Lobo NF, Collins FH, Hunt RH, Coetzee M,
Hemingway J, Ranson H: Two duplicated P450 genes are associated with
pyrethroid resistance in Anopheles funestus a major malaria vector.
Genome Res 2009, 19:452-459.
21. Kelly-Hope L, Ranson H, Hemingway J: Lessons from the past: managing
insecticide resistance in malaria control and eradication programmes.
Lancet Infect Dis 2008, DOI:10.1016/S1473-3099(08)70045-8.
22. Corbel V, Chandre F, Brengues C, Akogbeto M, Lardeux F, Hougard JM,
Guillet P: Dosage-dependent effects of permethrin-treated nets on the
behaviour of Anopheles gambiae and the selection of pyrethroid
resistance. Malar J 2004, 3:22.
23. N’Guessan R, Corbel V, Akogbeto M, Rowland M: Reduced efficacy of
insecticide-treated nets and indoor residual spraying for malaria control
in pyrethroid resistance area, Benin. Emerg Infect Dis 2007, 13:199-206.
24. Etang J, Chandre F, Guillet P, Manga L: Reduced bio-efficacy of
permethrin EC impregnated bednets against an Anopheles gambiae
strain with oxidase-based pyrethroid tolerance. Malar J 2004, 3:46.
25. Vulule JM: Elevated oxydase and esterase levels associated with
permethrin tolerance in Anopheles gambiae from Kenyan villages using
permethrin-impregnated net. Med Vet Entomol 1999, 13:239-244.
26. Vulule JM, Beach RF, Atieli FK, Roberts JM, Mount DL, Mwangi RW: Reduced
susceptibility of Anopheles gambiae to permethrin associated with the
use of permethrin-impregnated bednets and curtains in Kenya. Med Vet
Entomol 1994, 8:71-75.
27. Hardstone MC, Leichter CA, Scott JG: Multiplicative interaction between
the two major mechanisms of permethrin resistance, kdr and
cytochrome P450-monooxygenase detoxification, in mosquitoes. J Evol
Biol 2009, 22:416-423.
28. Berticat C, Bonnet J, Duchon S, Agnew P, Weill M, Corbel V: Costs and
benefits of multiple resistance to insecticides for Culex quinquefasciatus
mosquitoes. BMC Evol Biol 2008, 8:104.
29. WHO: Report of the twelfth WHOPES working group meeting. WHO/HTM/NTD/
WHOPES/20091 Geneva, WHOWHO_Pesticide_Evaluation_Scheme 2009, 1-120.
30. Bingham G, Gunning RV, Gorman K, Field LM, Moores GD: Temporal
synergism by microencapsulation of piperonyl butoxide and alpha-
cypermethrin overcomes insecticide resistance in crop pests. Pest Manag
Sci 2007, 63:276-281.
31. Corbel V, N’Guessan R, Brengues C, Chandre F, Djogbenou L, Martin T,
Akogbeto M, Hougard JM, Rowland M: Multiple insecticide resistance
mechanisms in Anopheles gambiae and Culex quinquefasciatus from
Benin, West Africa. Acta Trop 2007, 101:207-216.
32. Etang J, Manga L, Chandre F, Guillet P, Fondjo E, Mimpfoundi R, Toto JC,
Fontenille D: Insecticide susceptibility status of Anopheles gambiae s.l.
(Diptera: Culicidae) in the Republic of Cameroon. J Med Entomol 2003,
40:491-497.
33. Etang J, Manga L, Toto JC, Guillet P, Fondjo E, Chandre F: Spectrum of
metabolic-based resistance to DDT and pyrethroids in Anopheles
gambiae s.l. populations from Cameroon. J Vector Ecol 2007, 32:123-133.
34. Dabire KR, Diabate A, Pare-Toe L, Rouamba J, Ouari A, Fontenille D,
Baldet T: Year to year and seasonal variations in vector bionomics and
malaria transmission in a humid savannah village in west Burkina Faso. J
Vector Ecol 2008, 33:70-75.
35. Dabire KR, Diabate A, Namountougou M, Toe KH, Ouari A, Kengne P,
Bass C, Baldet T: Distribution of pyrethroid and DDT resistance and the
L1014F kdr mutation in Anopheles gambiae s.l. from Burkina Faso (West
Africa). Trans R Soc Trop Med Hyg 2009.
Corbel et al. Malaria Journal 2010, 9:113
http://www.malariajournal.com/content/9/1/113
Page 11 of 1236. WHO: Guidelines for testing mosquito adulticides intended for Indoor Residual
Spraying (IRS) and Insecticide Treated Nets (ITNs) 2006.
37. Scott JA, Brogdon WG, Collins FH: Identification of single specimens of
the Anopheles gambiae complex by the polymerase chain reaction. Am
J Trop Med Hyg 1993, 49:520-529.
38. Favia G, Lanfrancotti A, Spanos L, Siden Kiamos I, Louis C: Molecular
characterization of ribosomal DNA polymorphisms discriminating among
chromosomal forms of Anopheles gambiae s.s. Insect Mol Biol 2001,
10:19-23.
39. Pigeon OVJ-P, Boinon N, Demeulenaere J-L, Laduron L, Vandecandelaere S,
Wellin A, Herion V: Development, validation and performance verification of a
new method by GC-FID for the determination of deltamethrin and/or piperonyl
butoxide in Long-Lasting (incorporated into polyethylene) Insecticidal Mosquito
Nets CIPAC Technical Meeting San Salvador 2009.
40. Carnevale P, Robert V: Anopheles: Biologie, transmission du Plasmodium et
lutte antivectorielle Bondy: IRD 2009.
41. Gibson G, Torr SJ: Visual and olfactory responses of haematophagous
Diptera to host stimuli. Med Vet Entomol 1999, 13:2-23.
42. Lehane MJ: The biology of blood sucking in insects Cambridge: Cambridge
University Press 2005.
43. Chouaibou M, Simard F, Chandre F, Etang J, Darriet F, Hougard JM: Efficacy
of bifenthrin-impregnated bed nets against Anopheles funestus and
pyrethroid-resistant Anopheles gambiae in North Cameroon. Malar J
2006, 5:77.
44. Tungu P, Magesa S, Maxwell C, Malima R, Masue D, Sudi W, Myamba J,
Pigeon O, Rowland M: Evaluation of PermaNet 3.0 a deltamethrin-PBO
combination net against Anopheles gambiae and pyrethroid resistant
Culex quinquefasciatus mosquitoes: an experimental hut trial in Tanzania.
Malar J 2010, 9:21.
45. Van Bortel W, Chinh VD, Berkvens D, Speybroeck N, Trung HD,
Coosemans M: Impact of insecticide-treated nets on wild pyrethroid
resistant Anopheles epiroticus population from southern Vietnam tested
in experimental huts. Malar J 2009, 8:248.
46. Donnelly MJ, Corbel V, Weetman D, Wilding CS, Williamson MS, Black WCt:
Does kdr genotype predict insecticide-resistance phenotype in
mosquitoes? Trends Parasitol 2009, 25:213-219.
47. Dabire RK, Diabate A, Baldet T, Pare-Toe L, Guiguemde RT, Ouedraogo JB,
Skovmand O: Personal protection of long lasting insecticide-treated nets
in areas of Anopheles gambiae s.s. resistance to pyrethroids. Malar J 2006,
5:12.
48. Diabate A, Chandre F, Rowland M, N’Guessan R, Duchon S, Dabire KR,
Hougard JM: The indoor use of plastic sheeting pre-impregnated with
insecticide for control of malaria vectors. Trop Med Int Health 2006,
11:597-603.
49. Chandre F, Darriet F, Manguin S, Brengues C, Carnevale P, Guillet P:
Pyrethroid cross resistance spectrum among populations of Anopheles
gambiae s.s. from Cote d’Ivoire. J Am Mosq Control Assoc 1999, 15:53-59.
50. Diabate A, Brengues C, Baldet T, Dabire KR, Hougard JM, Akogbeto M,
Kengne P, Simard F, Guillet P, Hemingway J, Chandre F: The spread of the
Leu-Phe kdr mutation through Anopheles gambiae complex in Burkina
Faso: genetic introgression and de novo phenomena. Trop Med Int Health
2004, 9:1267-1273.
51. Pinto J, Lynd A, Vicente JL, Santolamazza F, Randle NP, Gentile G,
Moreno M, Simard F, Charlwood JD, do Rosario VE, Caccone A, Della
Torre A, Donnelly MJ: Multiple origins of knockdown resistance
mutations in the Afrotropical mosquito vector Anopheles gambiae. PLoS
ONE 2007, 2:e1243.
52. Ranson H, Abdallah H, Badolo A, Guelbeogo WM, Kerah-Hinzoumbe C,
Yangalbe-Kalnone E, Sagnon N, Simard F, Coetzee M: Insecticide resistance
in Anopheles gambiae: data from the first year of a multi-country study
highlight the extent of the problem. Malar J 2009, 8:299.
53. Hougard JM, Corbel V, N’Guessan R, Darriet F, Chandre F, Akogbeto M,
Baldet T, Guillet P, Carnevale P, Traore-Lamizana M: Efficacy of mosquito
nets treated with insecticide mixtures or mosaics against insecticide
resistant Anopheles gambiae and Culex quinquefasciatus (Diptera:
Culicidae) in Cote d’Ivoire. Bull Entomol Res 2003, 93:491-498.
54. Pennetier C, Corbel V, Boko P, Odjo A, N’Guessan R, Lapied B, Hougard JM:
Synergy between repellents and non-pyrethroid insecticides strongly
extends the efficacy of treated nets against Anopheles gambiae. Malar J
2007, 6:38.
55. Pennetier C, Corbel V, Hougard JM: Combination of a non-pyrethroid
insecticide and a repellent: a new approach for controlling knockdown-
resistant mosquitoes. Am J Trop Med Hyg 2005, 72:739-744.
56. Pennetier C, Costantini C, Corbel V, Licciardi S, Dabire RK, Lapied B,
Chandre F, Hougard JM: Mixture for controlling insecticide-resistant
malaria vectors. Emerg Infect Dis 2008, 14:1707-1714.
57. Pennetier C, Costantini C, Corbel V, Licciardi S, Dabire RK, Lapied B,
Chandre F, Hougard JM: Synergy between repellents and
organophosphates on bed nets: efficacy and behavioural response of
natural free-flying Anopheles gambiae mosquitoes. PLoS ONE 2009, 4:
e7896.
58. Djenontin A, Chabi J, Baldet T, Irish S, Pennetier C, Hougard JM, Corbel V,
Akogbeto M, Chandre F: Managing insecticide resistance in malaria
vectors by combining carbamate-treated plastic wall sheeting and
pyrethroid-treated bed nets. Malar J 2009, 8:233.
doi:10.1186/1475-2875-9-113
Cite this article as: Corbel et al.: Field efficacy of a new mosaic long-
lasting mosquito net (PermaNet® 3.0) against pyrethroid-resistant
malaria vectors: a multi centre study in Western and Central Africa.
Malaria Journal 2010 9:113.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Corbel et al. Malaria Journal 2010, 9:113
http://www.malariajournal.com/content/9/1/113
Page 12 of 12